George Dimopoulos

George Dimopoulos is a Professor at the Bloomberg School of Public Health, Johns Hopkins University, affiliated with the Department of Molecular Microbiology and Immunology and the Johns Hopkins Malaria Research Institute. His research focuses on molecular mechanisms of mosquito innate immunity and microbiota interactions with pathogens.

• PhD (1996) - University of Crete & Institute of Molecular Biology and Biotechnology
• MBA (2008) - Johns Hopkins Carey Business School
• BSc (1990) - Stockholm University

Dimopoulos investigates how mosquito immune responses and gut microbiota can block malaria, dengue, and Zika transmission. His work includes developing genetically modified mosquitoes and microbial biopesticides for disease control. Research spans molecular entomology, functional genomics, and public health applications.

Recent publications highlight advances in CRISPR/Cas9 gene editing for malaria suppression, mosGILT antibodies disrupting Plasmodium sporogony, and off-grid molecular diagnostics for malaria surveillance. His team explores biopesticides, immune pathway modulation, and microbiota engineering as novel control strategies.

• Elected member of Delta Omega Public Health Honor Society (2018)
• Shikani/El-Hibri Prize for Discovery & Innovation (2018)
• Member of American Academy of Microbiology (2016)
• Ellison Medical Foundation Young Investigator Award (2004-2008)

His work integrates innate immunity, vector biology, and global health to address challenges in mosquito-borne disease control. Collaborations include institutions in Africa, Asia, and Europe, with a focus on translational applications for malaria and dengue eradication.